-The Business Standard A CACP study shows how the Fisc, rising farm wages and international forces are stoking inflation It's good to see that independent thought is still present in the government. When one part of the government comes out with a serious and objective piece on how the government itself has been responsible for creating food inflation, hopefully the government is more likely to take note. The Commission for Agricultural Costs and...
More »SEARCH RESULT
Total Matching Records found : 2576
Not by inputs alone -Yamini Aiyar
-The Indian Express April 1 marked the third anniversary of the passage of the Right of Children for Free and Compulsory Education (RTE). There is little argument that the implementation of the RTE in these three years has been less than satisfactory. Deadlines for the enforcement of input norms - infrastructure, pupil-teacher ratios - have come and gone and potentially game-changing provisions, like 25 per cent reservation for economically weaker sections...
More »NHRC seeks proper action against HC Registrar General-J Venkatesan
-The Hindu Taking a serious view of the inordinate delay in disbursal of the amount that led to the suicide of the parents of one of the engineers of a ship ‘Pratibha Cauvery,' the National Human Rights Commission has asked the acting Chief Justice of the Madras High Court to take appropriate action against Registrar General G. Chockalingam for his failure to perform his duty. In early March, the National Commission for...
More »HIV, cancer patients seek access to affordable medicines-Aarti Dhar
-The Hindu Protesters see attempt by EU to undermine Indian judiciary in the EU-FTA pact People living with HIV, cancer patient groups and public health activists came out on the streets on Wednesday demanding that India reject the European Union's demands in the European Union-India Free Trade Agreement (EU-India FTA) negotiations. The protests coincide with Prime Minister Manmohan Singh's visit to Germany to meet Chancellor Angela Merkel with the FTA on top of...
More »More battles in store-Aarti Dhar
-The Hindu Well before the Supreme Court rejected Novartis' application for patent for Glivec (Gleevec in the U.S.), drawing Attention to the dichotomy of generic and patented drugs, activists have been demanding access to expensive drugs used in the treatment of cancer, hepatitis C and serious HIV. Trastuzumab is one such, used in the treatment of HER2+ type of breast cancer, which affects about one in four patients with the disease. Rough...
More »
